skip to main
|
skip to sidebar
Blog Archives: Nov 2004 - present
Special items: Ovarian Cancer and Us blog best viewed in Firefox
The complete article is available as a provisional PDF.
Background
About half of Americans 50 to 75 years old do not follow recommended colorectal cancer (CRC) screening guidelines, leaving 40 million individuals unscreened. A simple blood test would increase
screening compliance, promoting early detection and better patient outcomes. The objective of this study is to demonstrate the performance of an improved sensitivity blood-based Septin 9 (SEPT9) methylated
DNA test for colorectal cancer. Study variables include clinical stage, tumor location and histologic grade.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.